Scalfari A - Search Results

1

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.

Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R. Calabrese M, et al. Among authors: scalfari a. Ann Neurol. 2024 Jul;96(1):1-20. doi: 10.1002/ana.26913. Epub 2024 Apr 3. Ann Neurol. 2024. PMID: 38568026 Review.

2

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.

Scalfari A. Scalfari A. Mult Scler. 2015 Oct;21(11):1371-4. doi: 10.1177/1352458515599452. Mult Scler. 2015. PMID: 26438304 No abstract available.

3

Reply to Oluf Anderson's reply: Predicting a window of therapeutic opportunity in multiple sclerosis.

Ebers G, Daumer M, Scalfari A. Ebers G, et al. Among authors: scalfari a. Brain. 2011 May;134(Pt 5):e175; author reply e176. doi: 10.1093/brain/awq338. Epub 2011 Feb 8. Brain. 2011. PMID: 21303856 No abstract available.

4

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.

Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC. Scalfari A, et al. Brain. 2010 Jul;133(Pt 7):1914-29. doi: 10.1093/brain/awq118. Epub 2010 Jun 9. Brain. 2010. PMID: 20534650 Free PMC article.

5

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC. Scalfari A, et al. JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599. JAMA Neurol. 2013. PMID: 23407713

6

Mortality in patients with multiple sclerosis.

Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Scalfari A, et al. Neurology. 2013 Jul 9;81(2):184-92. doi: 10.1212/WNL.0b013e31829a3388. Neurology. 2013. PMID: 23836941 Free PMC article. Review.

7

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.

Calabrese M, Reynolds R, Magliozzi R, Castellaro M, Morra A, Scalfari A, Farina G, Romualdi C, Gajofatto A, Pitteri M, Benedetti MD, Monaco S. Calabrese M, et al. Among authors: scalfari a. PLoS One. 2015 Aug 12;10(8):e0135428. doi: 10.1371/journal.pone.0135428. eCollection 2015. PLoS One. 2015. PMID: 26267665 Free PMC article.

8

The relationship of age with the clinical phenotype in multiple sclerosis.

Scalfari A, Lederer C, Daumer M, Nicholas R, Ebers GC, Muraro PA. Scalfari A, et al. Mult Scler. 2016 Nov;22(13):1750-1758. doi: 10.1177/1352458516630396. Epub 2016 Feb 11. Mult Scler. 2016. PMID: 26869531

9

Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.

Nandoskar A, Raffel J, Scalfari AS, Friede T, Nicholas RS. Nandoskar A, et al. Among authors: scalfari as. Drugs. 2017 May;77(8):885-910. doi: 10.1007/s40265-017-0726-0. Drugs. 2017. PMID: 28429241 Review.

10

The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.

Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M. Scalfari A, et al. Neurology. 2018 Jun 12;90(24):e2107-e2118. doi: 10.1212/WNL.0000000000005685. Epub 2018 May 16. Neurology. 2018. PMID: 29769373 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters